Skip to main content
Clinical Trials/CTRI/2024/07/070626
CTRI/2024/07/070626
Not yet recruiting
未知

Evaluation of skin irritation and skin sensitization / hypo-allergenic potential claims ofVenusia Ureka Cream using Human Repeat Insult Patch Test (HRIPT). - NI

Dr. Reddys Laboratories Ltd.,0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr. Reddys Laboratories Ltd.,
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dr. Reddys Laboratories Ltd.,

Eligibility Criteria

Inclusion Criteria

  • 1\. Voluntary men and/or women between 18 and 65 years with 50 participants having
  • sensitive skin as determined by lactic acid sting test @ .
  • 2\. Fitzpatrick skin type III to V.
  • 3\. Having apparently healthy skin on test area.
  • 4\. For whom the Investigator considers that the compliance will be correct.
  • 5\. Cooperating, informed of the need and duration of the examinations, and ready to comply
  • with protocol procedures.
  • 6\. Willing to give written informed consent to participate in the trial after informing all
  • information concerning the trial procedures and trial objectives.
  • 7\. Willingness to avoid intense UV exposure on test site (sun or artificial UV), during the

Exclusion Criteria

  • 1\. Pregnancy (by UPT) and lactating women.
  • 2\. Scars, excessive terminal hair, or tattoo on the studied area.
  • 3\. A participant who the Investigator feels will not be compliant with trial requirements
  • 4\. Dermatological infection/pathology on the level of studied area.
  • 5\. Hypersensitivity, allergy antecedent (to any cosmetic product, raw material, hair dye).
  • 6\. Any clinically significant systemic or cutaneous disease, which may interfere with trial
  • procedures.
  • 7\. Chronic illness which may influence the outcome of the trial.
  • 8\. Participants on any medical treatment either systemic or topical which may interfere with
  • the performance of the trial (presently or in the past 1 month).

Outcomes

Primary Outcomes

Not specified

Similar Trials